Potassium Acetate Injection, Solution, Concentrate
Product Images NDC 65219-510

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Acetate (NDC 65219-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fresenius Kabi Logo (Pot0x 0002 01)

FDA Label Image

Package Label (Principal Display Panel – Potassium Acetate Injection, USP 20 mL Vial Label)

Label for Potassium Acetate Injection USP, 40 mEq/20 mL (2 mEq/mL) single-dose intravenous solution concentrate. The label indicates it is Rx only, must be diluted before use, sterile and nonpyrogenic. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL, with NDC 65219-510-02. The label includes dosing information, warnings, and a barcode.*

FDA Label Image

Package Label (Principal Display Panel – Potassium Acetate Injection, USP 20 mL Tray Label)

Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) concentrate for intravenous use. The label indicates this is a 20 mL single-dose vial with a caution to dilute before use. The product is labeled by Fresenius Kabi USA, LLC, with instructions for aseptic technique, storage at controlled room temperature, and ingredient details including potassium acetate concentration and pH.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.